Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ISRCTN17218321) titled 'Evaluating tools to communicate scleroderma research results to patients - trial #2' on Oct. 27.
Study Type: Interventional
Study Design:
Two-arm parallel-group randomized controlled trial (Quality of life)
Primary Sponsor: Jewish General Hospital
Condition:
Comparison of research dissemination tools to people living with systemic sclerosis (SSc
scleroderma)
Other
Intervention:
The investigators will use the multinational Scleroderma Patient-centered Intervention Network (SPIN) Cohort to conduct a series of RCTs to compare tools among people with systemic sclerosis, or scleroderma. The second trial in the se...